Otorhinolaryngology-Head and Neck Surgery, University Hospitals Leuven and Department of Oncology, Section Head and Neck Oncology, KU Leuven, Leuven, Belgium.
Division of Otolaryngology-Head and Neck Surgery, Southern Illinois University School of Medicine, Springfield, IL, USA.
Adv Ther. 2020 Apr;37(4):1360-1380. doi: 10.1007/s12325-020-01269-2. Epub 2020 Mar 5.
The optimal evidence-based prophylactic antibiotic regimen for surgical site infections following major head and neck surgery remains a matter of debate.
Medline, Cochrane, and Embase were searched for the current best evidence. Retrieved manuscripts were screened according to the PRISMA guidelines. Included studies dealt with patients over 18 years of age that underwent clean-contaminated head and neck surgery (P) and compared the effect of an intervention, perioperative administration of different antibiotic regimens for a variable duration (I), with control groups receiving placebo, another antibiotic regimen, or the same antibiotic for a different postoperative duration (C), on surgical site infection rate as primary outcome (O) (PICO model). A systematic review was performed, and a selected group of trials investigating a similar research question was subjected to a random-effects model meta-analysis.
Thirty-nine studies were included in the systematic review. Compared with placebo, cefazolin, ampicillin-sulbactam, and amoxicillin-clavulanate were the most efficient agents. Benzylpenicillin and clindamycin were clearly less effective. Fifteen studies compared short- to long-term prophylaxis; treatment for more than 48 h did not further reduce wound infections. Meta-analysis of five clinical trials including 4336 patients, where clindamycin was compared with ampicillin-sulbactam, implied an increased infection rate for clindamycin-treated patients (OR = 2.73, 95% CI 1.50-4.97, p = 0.001).
In clean-contaminated head and neck surgery, cefazolin, amoxicillin-clavulanate, and ampicillin-sulbactam for 24-48 h after surgery were associated with the highest prevention rate of surgical site infection.
对于头颈部大手术后手术部位感染的最佳循证预防抗生素方案仍存在争议。
检索 Medline、Cochrane 和 Embase 以获取当前最佳证据。根据 PRISMA 指南筛选检索到的文献。纳入的研究涉及年龄在 18 岁以上的接受清洁污染头颈部手术的患者(P),并比较了不同抗生素方案(I)在不同持续时间的围手术期给药与接受安慰剂、另一种抗生素方案或相同抗生素不同术后持续时间(C)的对照组对手术部位感染率的影响(O)(PICO 模型)。进行了系统评价,并对一组研究类似研究问题的试验进行了随机效应模型荟萃分析。
系统评价纳入 39 项研究。与安慰剂相比,头孢唑林、氨苄西林-舒巴坦和阿莫西林-克拉维酸是最有效的药物。青霉素 G 和克林霉素的效果明显较差。15 项研究比较了短期至长期预防;超过 48 小时的治疗并未进一步降低伤口感染率。荟萃分析了包括 4336 名患者的五项临床试验,其中克林霉素与氨苄西林-舒巴坦进行比较,表明克林霉素治疗组的感染率增加(OR=2.73,95%CI 1.50-4.97,p=0.001)。
在清洁污染的头颈部手术中,头孢唑林、阿莫西林-克拉维酸和氨苄西林-舒巴坦在术后 24-48 小时内使用与手术部位感染的最高预防率相关。